The obtained results may indicate that the increased BMPR2 concentration in women with endometriosis results from the increased release of the soluble form of this receptor into the peritoneal fluid, and not from the reduced binding of BMPR-2 with the BMP-2 ligand on the surface of the ectopic endometrium cells. This evidence concerns the gene BMPR2 and endometriosis.